Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in Zimbabwe

Dolutegravir (DTG) use in combination with tenofovir and lamivudine (TLD) is scaling up in Africa. However, HIV drug resistance (HIVDR) data to DTG remain scarce in Zimbabwe. We assessed the prevalence and genetic mechanisms of DTG resistance in people living with HIV initiating on TLD. A prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouamou, Vinie, Washaya, Tendai, Ndhlovu, Chiratidzo Ellen, Manasa, Justen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534864/
https://www.ncbi.nlm.nih.gov/pubmed/37766288
http://dx.doi.org/10.3390/v15091882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534864/
https://www.ncbi.nlm.nih.gov/pubmed/37766288
http://dx.doi.org/10.3390/v15091882

Ejemplares similares